Study of Tumor Progression in vivo and in vitro using

使用体内和体外肿瘤进展研究

基本信息

  • 批准号:
    06671186
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

Five autonomous sublines, T4-OI320 (329), T4-OI320CY (320CY), T4-OI165 (165), T4-OI145 (145), and T4-OI96 (96), were established from the transpalantable hormone-dependent mouse mammary tumor, TPDMT-4 (T4), by passaging under different conditions. These autonomous tumors were characterized by rapid growth in DDD virgin mice and the parental T4 by no growth in them. Thus, 10^5320,210^4320CY,2*10^3165,2*10^3145 and 10^396 cells were co-injected with 5*10^5T4 cells into virgin mice to determine whether hormone-dependent tumor cells influence the growth of autonomous tumor cells or not. T4 cells retarded the growth of 320 and 320CY tumors but accelerated that of 165,145 and 96. Irradiated T4 cells stimulated the growth of all the sublines but 320. In three-dimensional collagen gel culture, 320 and 320CY cells formed branched or stellate structures similar to normal mammary glands as did T4, but 165,145 and 96 cells grew as rounded masses with knobs and showed completely different morphology. 165,145 and 96 cells but not the others had lung-colonizing capability. In the collagen gel culture system, an antibiotic protease inhibitor exerted a stronger growth-inhibiting effect on the metastatic than on the parent and non-metastatic tumors. Thus, the susceptibility of autonomous subline tumor cells to the growth-inhibitory regulation from the parenetal hormone-dependent tumor cells was well correlated with growth morphology within collagen gels and metastatic property. The results suggest that metastatically-competent tumor cell variants, once they appear, may have a growth advantage in hormone-dependent mammary tumors. Application of this in vitro sytem to human breast cancer is in progress.
以TPDMT-4(T4)为材料,通过不同条件传代,建立了T4-OI 320(329)、T4-OI 320 CY(320 CY)、T4-OI 165(165)、T4-OI 145(145)和T4-OI 96(96)五个自主亚系。这些自主肿瘤的特征是在DDD处女小鼠中快速生长,而亲代T4小鼠中没有生长。因此,将10^5320、210^4320CY、2 * 10^3165、2 *10^3145和10^396个细胞与5* 10^5个T4细胞共注射到未交配的小鼠体内,以确定依赖性肿瘤细胞是否影响自主肿瘤细胞的生长。T4细胞对320和320 CY肿瘤生长有抑制作用,对165、145和96肿瘤生长有促进作用。辐照的T4细胞刺激了除320以外的所有亚系的生长。320和320 CY细胞在三维胶原凝胶培养中形成类似于正常乳腺的分枝状或星状结构,但165、145和96细胞生长为圆形团块,并有结节,显示完全不同的形态。165、145和96细胞具有肺定殖能力,其余细胞无肺定殖能力。在胶原凝胶培养系统中,抗生素蛋白酶抑制剂对转移瘤的生长抑制作用强于对母体和非转移瘤的生长抑制作用。因此,自主亚系肿瘤细胞对来自亲代肿瘤细胞依赖性肿瘤细胞的生长抑制调节的敏感性与胶原凝胶内的生长形态和转移性质密切相关。结果表明,具有转移能力的肿瘤细胞变体一旦出现,可能在乳腺癌依赖性乳腺肿瘤中具有生长优势。这种体外系统在人乳腺癌中的应用正在进行中。

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
武田泰隆、松澤昭雄: "マウス正常乳腺上皮、ホルモン依存性乳癌および非依存性乳癌に及ぼすlysophosphatidic acidの影響についての検討." 乳癌基礎研究. (印刷中).
Yasutaka Takeda、Akio Matsuzawa:“溶血磷脂酸对小鼠正常乳腺上皮、激素依赖性乳腺癌和非依赖性乳腺癌的影响的研究(正在出版)。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuzawa, A. and Takeda, Y.: "Establishment of tumor dormant state following clinically complete cure of disseminated leukemia by chemotherapy in mice." In "Premalignancy and Tumor Dormancy" eds. R. H. Scheuermann and E. Yefenof. R. G. Landes Company, Ge
Matsuzawa, A. 和 Takeda, Y.:“通过小鼠化疗临床完全治愈播散性白血病后,建立肿瘤休眠状态。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuzawa,A,Nakano,H,Sakamoto,S,Yoshimoto,T: "Dramatic hyperplasia of Mtv-2+ lymph node grafts in Mtv-2〜 recipients and selective stimulation of Vβ14+ T cells in recipients'lymph nodes" J.immunol. 154. 1644-1652 (1995)
Matsuzawa,A,Nakano,H,Sakamoto,S,Yoshimoto,T:“Mtv-2〜受者中Mtv-2 +淋巴结移植物的剧烈增生以及受者淋巴结中Vβ14 + T细胞的选择性刺激”J.immunol。 154. 1644-1652 (1995)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sayama, K., Goto, Y., Iguchi, T., Takeda, Y., and Matsuzawa, A.: "Effects of an antibiotic protease inhibitor, actinonin on the growth within collagen gels of non-metastatic and metastatic mouse mammary tumors of the same origin." Cancer Letters. 94. 171-
Sayama, K.、Goto, Y.、Iguchi, T.、Takeda, Y. 和 Matsuzawa, A.:“抗生素蛋白酶抑制剂放线菌素对非转移性和转移性小鼠乳腺肿瘤胶原凝胶内生长的影响
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Takeda,K.Sayama,Y.Saegusa and A.Matsuzawa: "Ditterent interaction in vivo between hormone dependent mammary tumor cells and related autonomous subline tumor cells with diffrent degree of malignacy in mice" Int.J.Oncol.5. 379 (1994)
Y.Takeda、K.Sayama、Y.Saegusa 和 A.Matsuzawa:“小鼠体内激素依赖性乳腺肿瘤细胞与具有不同恶性程度的相关自主亚系肿瘤细胞之间的不同体内相互作用”Int.J.Oncol.5。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKEDA Yasutaka其他文献

TAKEDA Yasutaka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKEDA Yasutaka', 18)}}的其他基金

Basic study for Analysis of Intractable Resistant Tumor Cells and their Overcoming in Cancer Gene Therapy
难治性耐药肿瘤细胞分析及其在癌症基因治疗中克服的基础研究
  • 批准号:
    14571125
  • 财政年份:
    2002
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical Application of Tumor-specific Anti-tumor Immunity Induced by Tumor Cells Expressing Fas (CD95) Ligand
表达Fas(CD95)配体的肿瘤细胞诱导肿瘤特异性抗肿瘤免疫的临床应用
  • 批准号:
    13557097
  • 财政年份:
    2001
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic study for. Cancer Gene Therapy by Antitumor Effects Using Fas-Fas Ligand-Mediated Apoptosis
基础学习。
  • 批准号:
    12671144
  • 财政年份:
    2000
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study for cancer gene therapy through Fas-mediated apoptosis
通过 Fas 介导的细胞凋亡进行癌症基因治疗的研究
  • 批准号:
    10671099
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study on tumor cell/cell interactions using mouse mammary tumor models
使用小鼠乳腺肿瘤模型研究肿瘤细胞/细胞相互作用
  • 批准号:
    08671337
  • 财政年份:
    1996
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Elucidate spatial and temporal heterogenity using extracellare vesicles
使用细胞外囊泡阐明空间和时间异质性
  • 批准号:
    22K08787
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understand the relationships between upper mantle heterogenity and plate forming place
了解上地幔异质性与板块形成地点之间的关系
  • 批准号:
    20K04111
  • 财政年份:
    2020
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Defining Astrocyte Heterogenity Across the Brainstem Respiratory Circuit
定义脑干呼吸回路中星形胶质细胞的异质性
  • 批准号:
    9896328
  • 财政年份:
    2019
  • 资助金额:
    $ 1.41万
  • 项目类别:
Defining Astrocyte Heterogenity Across the Brainstem Respiratory Circuit
定义脑干呼吸回路中星形胶质细胞的异质性
  • 批准号:
    10019601
  • 财政年份:
    2019
  • 资助金额:
    $ 1.41万
  • 项目类别:
Dealing with Religious Heterogenity in Confessional Religious Edcuation. A Triangulative Study on the Status Quo of Religious Education at State Schools
处理认信宗教教育中的宗教异质性。
  • 批准号:
    401439582
  • 财政年份:
    2018
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Research Grants
Is keratoacanthoma a benign neoplasm?: Retrieval of heterogenity using proteomics.
角化棘皮瘤是良性肿瘤吗?:使用蛋白质组学检索异质性。
  • 批准号:
    25461716
  • 财政年份:
    2013
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ethnic Heterogenity and the Production of Inequality within Institutions in Educational Organizations from Early Childhood Onward (B01)
种族异质性和从幼儿期开始的教育组织机构内不平等的产生(B01)
  • 批准号:
    202179804
  • 财政年份:
    2011
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Collaborative Research Centres
Research on elimination of heterogenity of iPS cells that is believed to be causative in the tumor formation.
研究消除被认为是肿瘤形成原因的 iPS 细胞的异质性。
  • 批准号:
    23618003
  • 财政年份:
    2011
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The influence of spatial heterogenity on diversity
空间异质性对多样性的影响
  • 批准号:
    362166-2008
  • 财政年份:
    2010
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
The influence of spatial heterogenity on diversity
空间异质性对多样性的影响
  • 批准号:
    362166-2008
  • 财政年份:
    2009
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了